ACTIVE SUBSTANCES NO LONGER SUPPORTED IN GB



Following an opportunity for any person, company or task force/consortium to support the active substance/product type
combination listed in the GB Review Programme, no compliant dossier was received:

     * Monolinuron (CAS 1746-81-2 EC 217-129-5) in product type 2

In cases where active substance/product type combinations are not supported, GB biocides regulations require that these active
substance/product type combinations are subject to a GB non-approval decision.

Once a decision is taken, the active substances will no longer be able to be used in biocidal products of the relevant product type in GB. In
addition, articles treated with such products will no longer be able to be placed on the market in GB. HSE will provide separate updates on the
decision and relevant phase-out periods.

PLEASE NOTE:

If you are aware of any disproportionate negative impacts that are likely to arise from the non-approval of the active substance/product
type combination listed, please contact us by 16 May 2025.